What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Immune system
His scientific interests lie mostly in Immunology, Cancer, Cancer research, Immunotherapy and Cancer cell.
He interconnects Cytotoxic T cell and Breast cancer in the investigation of issues within Immunology.
His Cancer study combines topics in areas such as Immunohistochemistry, Lung cancer and Pathology.
His Cancer research study combines topics from a wide range of disciplines, such as Side population, Survivin and Sarcoma.
As a part of the same scientific family, Toshihiko Torigoe mostly works in the field of Immunotherapy, focusing on Antigen and, on occasion, Antibody, Molecular biology and Extracellular.
His Colorectal cancer research includes themes of Tumor progression and Oncology.
His most cited work include:
- Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. (794 citations)
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study (665 citations)
- Cancer classification using the Immunoscore: a worldwide task force (525 citations)
What are the main themes of his work throughout his whole career to date?
Toshihiko Torigoe mostly deals with Cancer research, Immunology, Cancer, Antigen and Immunotherapy.
Toshihiko Torigoe works mostly in the field of Cancer research, limiting it down to topics relating to Cancer cell and, in certain cases, Side population.
His study ties his expertise on Survivin together with the subject of Immunology.
The concepts of his Cancer study are interwoven with issues in Carcinoma, Pathology and Oncology.
His research integrates issues of Cytotoxic T cell, Molecular biology and Cell biology in his study of Antigen.
The various areas that he examines in his Immunotherapy study include Adoptive cell transfer, HLA-A24 and Melanoma.
He most often published in these fields:
- Cancer research (31.75%)
- Immunology (27.89%)
- Cancer (27.30%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (31.75%)
- Internal medicine (15.73%)
- Immune system (13.35%)
In recent papers he was focusing on the following fields of study:
Toshihiko Torigoe mainly investigates Cancer research, Internal medicine, Immune system, Cancer and Oncology.
His work deals with themes such as Cancer cell, Cancer stem cell, Human leukocyte antigen, Antigen and Immunotherapy, which intersect with Cancer research.
As part of one scientific family, Toshihiko Torigoe deals mainly with the area of Internal medicine, narrowing it down to issues related to the Gastroenterology, and often Brain metastasis, Progressive disease and Exacerbation.
The subject of his Immune system research is within the realm of Immunology.
The study incorporates disciplines such as Stage, Surgery, Phenotype and Pathology in addition to Cancer.
His studies in Oncology integrate themes in fields like Tegafur, Gemcitabine and Clinical endpoint.
Between 2017 and 2021, his most popular works were:
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study (665 citations)
- Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report. (23 citations)
- The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer. (22 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Immune system
Internal medicine, Oncology, Cancer, Cancer research and Immune system are his primary areas of study.
His Internal medicine study incorporates themes from Mucosal melanoma and Cutaneous melanoma.
His work carried out in the field of Oncology brings together such families of science as Colorectal cancer and Clinical endpoint.
His Cancer research incorporates themes from Disease and Antigen.
His research in Cancer research intersects with topics in Carcinogenesis, Cell and Cell culture, Gene knockdown.
CTL* is a subfield of Immunology that Toshihiko Torigoe tackles.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
